Skip to main content
SpringerLink
Log in
Book cover

Stroke Revisited: Vascular Cognitive Impairment pp 127–138Cite as

Pharmacological Treatment: Current Evidence for Clinical Uses of Alzheimer’s Disease Drugs

  • Chapter
  • First Online:

Part of the book series: Stroke Revisited ((STROREV))

Abstract

Alzheimer’s disease (AD) and vascular dementia (VaD) are the two most common forms of dementia. Cholinesterase inhibitors and N-methyl-d-aspartate receptor antagonists are approved and widely used in AD treatment. The role of these AD drugs for VaD is controversial. This chapter reviews the current evidence for the use of AD drugs in the treatment of VaD. To date, there have been eight published randomized controlled trials (three donepezil, two galantamine, one rivastigmine, and two memantine trials) evaluating the efficacy and safety of AD drugs in VaD. These clinical trials have demonstrated small benefits in cognitive function but without consistent corresponding effects on global function. Currently, there is not enough evidence to recommend widespread use of AD drugs in VaD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hébert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14(5):240–57.

    Article  Google Scholar 

  2. Ikeda M, Hokoishi K, Maki N, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology. 2001;57(5):839–44.

    Article  CAS  Google Scholar 

  3. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51(3):728–33.

    Article  CAS  Google Scholar 

  4. Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol. 2007;6(9):782–92.

    Article  CAS  Google Scholar 

  5. Takahashi A, Ikarashi Y, Maruyama Y. Immunohistochemical and neurochemical studies of hippocampal cholinergic neurones after ischaemia. Neuroreport. 1995;6(3):557–60.

    Article  Google Scholar 

  6. Ni J-W, Matsumoto K, Li H-B, et al. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res. 1995;673(2):290–6.

    Article  CAS  Google Scholar 

  7. Yamamuro Y, Iwano H, Sensui N, et al. Acetylcholine in the hippocampus during the discrimination learning performance in a rat model of chronic cerebral ischaemia. Neuroreport. 1996;7(11):1837–40.

    Article  CAS  Google Scholar 

  8. Togashi H, Matsumoto M, Yoshioka M, et al. Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Neurosci Lett. 1994;166(1):117–20.

    Article  CAS  Google Scholar 

  9. Gottfries C-G, Blennow K, Karlsson I, et al. The neurochemistry of vascular dementia. Dementia. 1994;5(3–4):163–7.

    CAS  PubMed  Google Scholar 

  10. Wallin A, Blennow K, Gottfries C. Neurochemical abnormalities in vascular dementia. Dementia. 1989;1:120–30.

    Google Scholar 

  11. Tohgi H, Abe T, Kimura M, et al. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. J Neural Transm. 1996;103(10):1211–20.

    Article  CAS  Google Scholar 

  12. Selden NR, Gitelman DR, Salamon-Murayama N, et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121(12):2249–57.

    Article  Google Scholar 

  13. Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology. 2003;60(7):1183–5.

    Article  Google Scholar 

  14. Orrego F, Villanueva S. The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization. Neuroscience. 1993;56(3):539–55.

    Article  CAS  Google Scholar 

  15. Danysz W, Parsons CG. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev. 1998;50(4):597–664.

    CAS  PubMed  Google Scholar 

  16. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci. 1990;11(9):379–87.

    Article  CAS  Google Scholar 

  17. Heim C, Sontag K. Memantine prevents progressive functional neurodegeneration in rats. J Neural Transm Suppl. 1994;46:117–30.

    Google Scholar 

  18. Frankiewicz T, Pilc A, Parsons CG. Differential effects of NMDA–receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices. Neuropharmacology. 2000;39(4):631–42.

    Article  CAS  Google Scholar 

  19. Orgogozo J-M, Rigaud A-S, Stöffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia. Stroke. 2002;33(7):1834–9.

    Article  CAS  Google Scholar 

  20. Möbius H-J. Pharmacologic rationale for memantine in chronic cerebral hypoperfusion, especially vascular dementia. Alzheimer Dis Assoc Disord. 1999;13:S172–8.

    Article  Google Scholar 

  21. Black S, Román GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia. Stroke. 2003;34(10):2323–30.

    Article  CAS  Google Scholar 

  22. Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61(4):479–86.

    Article  CAS  Google Scholar 

  23. Román GC, Salloway S, Black SE, et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia. Stroke. 2010;41(6):1213–21.

    Article  Google Scholar 

  24. Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002;359(9314):1283–90.

    Article  Google Scholar 

  25. Auchus A, Brashear H, Salloway S, et al. Galantamine treatment of vascular dementia: a randomized trial. Neurology. 2007;69(5):448–58.

    Article  CAS  Google Scholar 

  26. Ballard C, Sauter M, Scheltens P, et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin. 2008;24(9):2561–74.

    Article  CAS  Google Scholar 

  27. Wilcock G, Möbius HJ, Stöffler A, et al. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002;17(6):297–305.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Inha University School of Medicine, Incheon, South Korea

    Cindy W. Yoon

Authors
  1. Cindy W. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Seoul National University Hospital, Seoul, Korea (Republic of)

    Seung-Hoon Lee

  2. Department of Neurology, Hallym University Sacred Heart Hospital, Hallym Neurological Institute Hallym University College of Medicine, Anyang-si, Gyeonggi-do, Korea (Republic of)

    Jae-Sung Lim

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yoon, C.W. (2020). Pharmacological Treatment: Current Evidence for Clinical Uses of Alzheimer’s Disease Drugs. In: Lee, SH., Lim, JS. (eds) Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1433-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1433-8_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1432-1

  • Online ISBN: 978-981-10-1433-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation